Posted on 9/26/18
Syndax Announces Changes to its Board of Directors
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies
Posted on 9/25/18
Ra Pharma Elects Aoife M. Brennan, M.B., B.Ch., to Board of Directors
Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the election of Aoife M. Brennan, M.B., B.Ch., to its board of directors.
Posted on 9/25/18
KSQ Therapeutics Appoints Richard Moscicki, MD, to Board of Directors
KSQ Therapeutics today announced the appointment of Richard A. Moscicki, MD, to the company’s Board of Directors. Dr. Moscicki brings more than 25 years
Posted on 9/25/18
Zillion Appoints Healthcare Veteran Heather Provino to Board of Directors
Zillion, a leading health behavior architecture company, is pleased to announce the appointment of Heather Provino as a new member of the organization’s Board of Directors.
Posted on 9/24/18
AGTC Appoints William Aliski to its Board of Directors
Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus
Posted on 9/19/18
CCC Welcomes Brian Crawford, Cathy Wolfe and Deirdre Silver to Board of Directors
Copyright Clearance Center, Inc. (CCC) today announced the appointment of three new directors to the company’s board: Brian Crawford, Cathy Wolfe and Deirdre Silver.
Posted on 9/18/18
Clinical and Machine Learning Expert, Dr. Ziad Obermeyer Joins GNS Healthcare's Strategic Advisory Board
GNS Healthcare (GNS), a leading precision medicine company, today announced the appointment of Ziad Obermeyer, MD, Associate Professor of Health Policy
Posted on 9/18/18
Boston Heart Diagnostics Announces New Scientific Advisory Board Appointments
Boston Heart Diagnostics, one of the leading disease management laboratories in the United States, is pleased to announce the company’s
Posted on 9/18/18
Gamida Cell Appoints Robert Blum as Chairman
Gamida Cell, a leading cellular and immune therapeutics company, today announced the appointment of Robert Blum, president and chief executive officer of Cytokinetics, Inc.
Posted on 9/17/18
Stoke Therapeutics Appoints Arthur Tzianabos, Ph.D. To Board of Directors
Stoke Therapeutics, Inc., today announced that veteran biotech executive Arthur Tzianabos, Ph.D., who has extensive experience in the development and commercialization
Posted on 9/13/18
IFM Therapeutics Appoints John Leonard, M.D. to Board of Directors
IFM Therapeutics, LLC (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system t
Posted on 9/13/18
Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors
Bionik Laboratories Corp. (OTCQB: BNKL), a pioneering healthcare company combining artificial intelligence and innovative robotics technology to help individuals
Posted on 9/13/18
Solid Biosciences Appoints Sukumar Nagendran, M.D., To Its Board Of Directors
Solid Biosciences Inc. (NASDAQ: SLDB) today announced that Sukumar Nagendran, M.D., has been elected
Posted on 9/13/18
Mirador Appoints April Rudin to Its Board of Advisors
DARIEN, Conn.--(BUSINESS WIRE)--Mirador, LLC, the leading provider of bespoke portfolio-performance reporting solutions for high net-worth families, family offices, wealth management firms and more, has named to . . .
Posted on 9/12/18
Nuance Names Four New Independent Directors, Appoints Lloyd Carney as Chairman of the Board
Nuance Communications, Inc. (NASDAQ: NUAN) today announced that its Board of Directors has unanimously approved and appointed four new members to the Board
Posted on 9/12/18
ReversingLabs Appoints Doug Levin to its Board of Directors
CAMBRIDGE, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- ReversingLabs, a global leader in discovering and responding to unknown malware, today announced that Doug Levin has joined . . .
Posted on 9/12/18
United States Hispanic Chamber of Commerce Announces Additions to Board of Directors
Washington, DC, Sept. 12, 2018 (GLOBE NEWSWIRE) -- The United States Hispanic Chamber of Commerce (USHCC) is proud to announce the addition of six new members . . .
Posted on 9/12/18
Biohaven Appoints Bob Repella to Board of Directors
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the appointment of Robert (Bob) Repella to its Board of Directors.
Posted on 9/12/18
Renovia Appoints Dan Levangie to Its Board of Directors
Renovia Inc., a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders
Posted on 9/12/18
CTO of IBM Blockchain Gari Singh Joins Muirfield Advisory Board
BOSTON--(BUSINESS WIRE)--Boston-based private equity real estate firm, Muirfield Investment Partners, is pleased to announce that blockchain specialist and CTO of IBM Blockchain, Gari Singh, has joined . . .
Posted on 9/11/18
Andrew Cheng, MD, PhD Joins Akero Therapeutics as CEO
Akero Therapeutics, Inc., a biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases
Posted on 9/11/18
EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Chairman of Board of Directors
WATERTOWN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that . . .
Posted on 9/10/18
Trilio Appoints John R. Egan, of Egan-Managed Capital, to its Board of Directors
Trilio, the leader in cloud-native data protection solutions for OpenStack and KVM, today announced the appointment of John R. Egan
Posted on 9/10/18
EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Next Chairman of Board of Directors
EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products
Posted on 9/9/18
Cytogel Pharma Appoints Alan W. Dunton, M.D. to its Board of Managers
C. Dean Maglaris, CEO of Cytogel Pharma, announced today that Alan W. Dunton, M.D. has been named to the Board of Cytogel.
Boston
